ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Technical Lead Architect (R5), PR&D at Eli Lilly and Company - ApplyBlast

Technical Lead Architect (R5), PR&D

Eli Lilly and Company

19 days ago

4.0 on Glassdoor

Bengaluru, Karnataka, India

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Technical Lead Architect (R5) at Lilly's Product Research & Development (PR&D) department builds and owns the Semantic Layer and Knowledge Graph to unify fragmented CMC data for human and AI use. This hands-on role involves designing ontologies, engineering knowledge graphs, and deploying agentic architectures to enable reliable, governed AI-assisted scientific workflows. The position requires technical leadership of engineering teams while partnering with business stakeholders to drive the semantic layer roadmap and ensure compliance with regulatory standards.

Responsibilities

Design and build unified knowledge graphs and semantic layers for CMC data
Develop multi-agent architectures and orchestration patterns for scientific workflows
Lead technical roadmap and mentor engineering teams while ensuring GxP compliance

Skills

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.